CHF231.00
1.32%
SIX Swiss Exchange, Sep 25, 02:00 pm CEST. Market open.
ISIN
CH0012627250
Symbol
HBMN

HBM Healthcare Investments Target price 2026 - Analyst rating & recommendation

HBM Healthcare Investments Classifications & Recommendation

Buy
88%
Hold
13%

HBM Healthcare Investments Price Target

Target Price CHF285.60
Price CHF228.00
Potential
Number of Estimates 4
4 Analysts have issued a price target HBM Healthcare Investments 2027 . The average HBM Healthcare Investments target price is CHF285.60. This is higher than the current stock price. The highest price target is
CHF294.00 28.95%
register free of charge
, the lowest is
CHF282.80 24.04%
register free of charge
.
A rating was issued by 8 analysts: 7 Analysts recommend HBM Healthcare Investments to buy, 1 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the HBM Healthcare Investments stock has an average upside potential 2027 of . Most analysts recommend the HBM Healthcare Investments stock at Purchase.

Sales and Margin forecast 2027, 2028 & 2029

Create a premium account to unlock analyst estimates. Learn more

Select at least one metric to display the chart.


Mar '26 2027
Estimates
Revenue Million CHF 297.06 314.16
607.12% 5.76%
Net Margin 91.51% 98.52%
107.36% 7.66%

3 Analysts have issued a sales forecast HBM Healthcare Investments 2027 . The average HBM Healthcare Investments sales estimate is

CHF314m
unlock
. This is
55.97% lower
unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
CHF323m 54.67%
unlock
, the lowest is
CHF302m 57.69%
unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2026 CHF297m 607.12%
2027
CHF314m 5.76%
unlock
2028
CHF167m 46.75%
unlock
2029
CHF171m 2.44%
unlock

3 HBM Healthcare Investments Analysts have issued a net profit forecast 2027. The average HBM Healthcare Investments net profit estimate is

CHF310m
unlock
. This is
52.40% lower
unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
CHF319m 51.00%
unlock
, the lowest is
CHF297m 54.26%
unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2026 CHF272m 1,366.29%
2027
CHF310m 13.86%
unlock
2028
CHF163m 47.39%
unlock
2029
CHF167m 2.47%
unlock

Net Margin

2026 91.51% 107.36%
2027
98.52% 7.66%
unlock
2028
97.34% 1.20%
unlock
2029
97.37% 0.03%
unlock

Earnings per share, P/E ratio and EV/sales Estimates 2027, 2028 & 2029

Create a premium account to unlock analyst estimates. Learn more

Select at least one metric to display the chart.


Mar '26 2027
Estimates
Earnings Per Share CHF 40.74 46.90
1,397.79% 15.12%
P/E 4.86
EV/Sales 5.43

3 Analysts have issued a HBM Healthcare Investments forecast for earnings per share. The average HBM Healthcare Investments EPS is

CHF46.90
unlock
. This is
52.36% lower
unlock
than earnings per share in the financial year 2026. The highest EPS forecast is
CHF48.28 50.96%
unlock
, the lowest is
CHF45.06 54.23%
unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2026 CHF40.74 1,397.79%
2027
CHF46.90 15.12%
unlock
2028
CHF24.67 47.40%
unlock
2029
CHF25.28 2.47%
unlock

P/E ratio

Current 2.32 129.56%
2027
4.86 109.85%
unlock
2028
9.24 90.12%
unlock
2029
9.02 2.38%
unlock

Based on analysts' sales estimates for 2027, the HBM Healthcare Investments stock is valued at an EV/Sales of

and an P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 2.39 123.66%
2027
5.43 127.04%
unlock
2028
10.19 87.81%
unlock
2029
9.95 2.38%
unlock

P/S ratio

Current
2027
4.92 127.09%
unlock
2028
9.24 87.81%
unlock
2029
9.02 2.38%
unlock

Current HBM Healthcare Investments Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
BAADER EUROPE
Locked
➜
Locked
Locked Jul 30 2026
ESN/CIC MARKET SOLUTIONS
Locked
➜
Locked
Locked Jun 18 2026
ESN/CIC MARKET SOLUTIONS
Locked
➜
Locked
Locked Jun 17 2026
BAADER HELVEA EQUITY RESEARCH
Locked
➜
Locked
Locked Jan 23 2026
BAADER HELVEA EQUITY RESEARCH
Locked
➜
Locked
Locked Jan 22 2026
ESN/CIC MARKET SOLUTIONS
Locked
➜
Locked
Locked Dec 15 2025
ESN/CIC MARKET SOLUTIONS
Locked
➜
Locked
Locked Oct 13 2025
Analyst Rating Date
Locked
BAADER EUROPE:
Locked
➜
Locked
Jul 30 2026
Locked
ESN/CIC MARKET SOLUTIONS:
Locked
➜
Locked
Jun 18 2026
Locked
ESN/CIC MARKET SOLUTIONS:
Locked
➜
Locked
Jun 17 2026
Locked
BAADER HELVEA EQUITY RESEARCH:
Locked
➜
Locked
Jan 23 2026
Locked
BAADER HELVEA EQUITY RESEARCH:
Locked
➜
Locked
Jan 22 2026
Locked
ESN/CIC MARKET SOLUTIONS:
Locked
➜
Locked
Dec 15 2025
Locked
ESN/CIC MARKET SOLUTIONS:
Locked
➜
Locked
Oct 13 2025

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today